ArticleInternational journal of surgery case reports2026
Transcatheter arterial embolization enabling curative surgery for bleeding locally advanced breast cancer: a case report.
Article in International journal of surgery case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction and importance: Locally advanced breast cancer (LABC), defined as stage IIIB or IIIC disease without distant metastasis, is generally managed with systemic therapy as the initial treatment. However, uncontrolled bleeding from fungating tumors may interrupt treatment continuity and render definitive surgery unfeasible. Although endovascular therapy is occasionally used as an emergency hemostatic measure, its role in enabling curative surgery remains insufficiently documented. We report a case of LABC in which transcatheter arterial embolization (TAE) successfully controlled tumor bleeding and enabled subsequent definitive resection. Presentation of case: A 66-year-old woman with untreated breast cancer presented with massive hemorrhage from a rapidly enlarging fungating tumor, resulting in transient loss of consciousness. Contrast-enhanced computed tomography revealed a 10-cm left breast mass with axillary and supraclavicular lymphadenopathy without distant metastasis (T4bN3cM0, stage IIIC). Persistent bleeding initially precluded definitive oncologic treatment. Endovascular embolization of the internal mammary and lateral thoracic arteries was performed on the second hospital day, achieving immediate and sustained hemostasis. Clinical discussion: Hemorrhage control enabled uninterrupted radiotherapy and endocrine therapy, leading to marked tumor regression. Subsequent total mastectomy with axillary dissection was performed without skin grafting, and pathology demonstrated minimal residual disease with no nodal metastasis. Conclusion: TAE may provide rapid and durable hemorrhage control, thereby allowing uninterrupted multimodal therapy and ultimately enabling curative surgery in selected patients with LABC.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.